Coronis Health appoints Pranil Vadgama CEO, launches AI-focused growth push
What's the deal? Coronis HealthDealroom has a profile for this one. Try Dealroom →, a healthcare revenue cycle management company, has appointed Pranil Vadgama as its new chief executive officer and president to lead a strategic growth initiative backed by additional investment from its existing financial partners. The initiative targets AI-enabled automation, workflow intelligence, analytics, and scalable operational infrastructure.
Vadgama brings more than 30 years of global leadership experience across healthcare, operations, and enterprise transformation. He previously served as CEO and president of Health Prime RCM and held senior roles at R1 RCM, BramblesDealroom has a profile for this one. Try Dealroom →, and GE.
Former CEO Stuart Gleichenhaus will stay on in a consultative capacity to support the transition.
Why now? Healthcare organisations face mounting pressure to cut costs and streamline billing while maintaining patient care quality. Advances in AI and automation have opened new possibilities for revenue cycle management — the complex back-office process of tracking claims, payments, and reimbursements — and Coronis Health wants to position itself at the front of that shift.
"Healthcare organizations are under increasing pressure to operate more efficiently while continuing to deliver exceptional patient experiences," Vadgama said.
What could go wrong? The company hasn't disclosed the size of its new investment, making it hard to gauge the scale of ambition. Healthcare IT is a crowded market, with incumbents like R1 RCM and a wave of AI-native startups competing for the same contracts. Integrating AI into highly regulated healthcare workflows also carries compliance and accuracy risks that could slow deployment.
The signal: Coronis Health is classified as an early-growth company on Dealroom, making this leadership shake-up and undisclosed investment round a bet that the firm can leap from niche revenue cycle management provider to a scaled, AI-augmented platform before larger incumbents — and a growing crop of AI-native startups — lock up hospital and health system contracts. The choice to bring in a former R1 RCM and GE executive underscores that the real battleground in healthcare revenue operations is less about building novel AI models and more about deploying them reliably across complex, regulated workflows at global scale.
Read more: Benzinga
